![Peter C. Agre](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter C. Agre
Direktor/Vorstandsmitglied bei Aeromics, Inc.
Aktive Positionen von Peter C. Agre
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aeromics, Inc.
![]() Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Direktor/Vorstandsmitglied | 09.09.2019 | - |
Karriereverlauf von Peter C. Agre
Ehemalige bekannte Positionen von Peter C. Agre
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
American Association for the Advancement of Science
![]() American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Vorsitzender | 17.11.2010 | - |
Ausbildung von Peter C. Agre
Augsburg College | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chairman | 1 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Aeromics, Inc.
![]() Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | Health Technology |
American Association for the Advancement of Science
![]() American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Commercial Services |
- Börse
- Insiders
- Peter C. Agre
- Erfahrung